Erik Digman WiklundCEO at CircioSpeaker
Profile
Erik is a molecular biologist by background and co-discoverer of human circular RNA and its natural functionality. For the past 15 years, he has worked in executive roles in the biotech industry and as a consultant in the pharma and healthcare practice at McKinsey & Co. He is currently the CEO of Circio, a pioneer in the area of vector expressed circular RNA for gene therapy.
Agenda Sessions
Deploying Circular RNA Expression to Boost Gene Therapy – AAV And Beyond
, 12:25pmView Session